{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:23:13Z","timestamp":1790864593295,"version":"4.1.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>This review focuses on the molecular biology of head and neck squamous cell carcinomas and presents current and emerging biomarkers of the response of patients to induction chemotherapy. The usefulness of genes, proteins, and parameters from diagnostic clinical imaging as well as other clinicopathological parameters is thoroughly discussed. The role of induction chemotherapy before radiotherapy or before chemo-radiotherapy is still debated, as the data on its efficacy are somehow confusing. Despite the constant improvement of treatment protocols and the introduction of new cytostatics, there is still no consensus regarding the use of induction chemotherapy in the treatment of head and neck cancer, with the possible exception of larynx preservation. Such difficulties indicate that potential future treatment strategies should be personalized. Personalized medicine, in which individual tumor genetics drive the selection of targeted therapies and treatment plans for each patient, has recently emerged as the next generation of cancer therapy. Early prediction of treatment outcome or its toxicity may be highly beneficial for those who are at risk of the development of severe toxicities or treatment failure\u2014a different treatment strategy may be applied to these patients, sparing them unnecessary pain. The literature search was carried out in the PubMed and ScienceDirect databases as well as in the selected conference proceedings repositories. Of the 265 articles and abstracts found, only 30 met the following inclusion criteria: human studies, analyzing prediction of induction chemotherapy outcome or toxicity based on the pretreatment (or after the first cycle, if more cycles of induction were administered) data, published after the year 2015. The studies regarding metastatic and recurrent cancers as well as the prognosis of overall survival or the outcome of consecutive treatment were not taken into consideration. As revealed from the systematic inspection of the papers, there are over 100 independent parameters analyzed for their suitability as prognostic markers in HNSCC patients undergoing induction chemotherapy. Some of them are promising, but usually they lack important features such as high specificity and sensitivity, low cost, high positive predictive value, clinical relevance, short turnaround time, etc. Subsequent studies are necessary to confirm the usability of the biomarkers for personal medicine.<\/jats:p>","DOI":"10.3389\/fonc.2022.900903","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:03:51Z","timestamp":1657127031000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Predictive Biomarkers for Response and Toxicity of Induction Chemotherapy in Head and Neck Cancers"],"prefix":"10.3389","volume":"12","author":[{"given":"\u0141ukasz","family":"Boguszewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8934","article-title":"Neoadjuvant Modified TPF (Docetaxel, Cisplatin, Fluorouracil) for Patients Unfit to Standard TPF in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study of 48 Patients","author":"Fayette","year":"2016","journal-title":"Oncotarget"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy102","article-title":"Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Role, Controversy, and Future Directions","author":"Haddad","year":"2018","journal-title":"Ann Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.6309","article-title":"Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer","volume":"32","author":"Cohen","year":"2014","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3892\/mco.2017.1281","article-title":"Efficacy and Toxicity of Docetaxel Combination Chemotherapy for Advanced Squamous Cell Cancer of the Head and Neck","volume":"7","author":"Albers","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S3133","article-title":"Docetaxel in the Treatment of Squamous Cell Carcinoma of the Head and Neck","volume":"4","author":"Rapidis","year":"2008","journal-title":"Ther Clin Risk Manage"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2019.01.002","article-title":"Cisplatin and Fluorouracil Induction Chemotherapy With or Without Docetaxel in Locoregionally Advanced Nasopharyngeal Carcinoma","volume":"12","author":"Jin","year":"2019","journal-title":"Transl Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/srep24835","article-title":"The Tumour Response to Induction Chemotherapy has Prognostic Value for Long-Term Survival Outcomes After Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma","volume":"6","author":"Peng","year":"2016","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-07347-6","article-title":"Dose-Dense TPF Induction Chemotherapy for Locally Advanced Head and Neck Cancer: A Phase II Study","volume":"20","author":"Hsieh","year":"2020","journal-title":"BMC cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyx115","article-title":"Chemo-Selection With Docetaxel, Cisplatin and 5-Fluorouracil (TPF) Regimen Followed by Radiation Therapy or Surgery for Pharyngeal and Laryngeal Carcinoma","volume":"47","author":"Matoba","year":"2017","journal-title":"Japanese J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejca.2015.09.024","article-title":"Induction Chemotherapy With Docetaxel\/Cisplatin\/5-Fluorouracil Followed by Randomization to Two Cisplatin-Based Concomitant Chemoradiotherapy Schedules in Patients With Locally Advanced Head and Neck Cancer (CONDOR Study) (Dutch Head and Neck Society 08-01): A Randomized Phase II Study","volume":"52","author":"Driessen","year":"2016","journal-title":"Eur J Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215115002479","article-title":"Biomarkers Predicting Chemotherapy Response in Head and Neck Squamous Cell Carcinoma: A Review","volume":"129","author":"Cosway","year":"2015","journal-title":"J Laryngol Otol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New Response Evaluation Criteria in Solid Tumours: Revised RECIST Guideline (Version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-31027-y","article-title":"A Response Prediction Model for Taxane, Cisplatin, and 5-Fluorouracil Chemotherapy in Hypopharyngeal Carcinoma","volume":"8","author":"Zhong","year":"2018","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2017.1521","article-title":"Predictive Biomarkers for Combined Chemotherapy With 5-Fluorouracil and Cisplatin in Oro- and Hypopharyngeal Cancers","volume":"8","author":"Hasegawa","year":"2018","journal-title":"Mol Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.wjorl.2019.05.001","article-title":"Screening of Molecular Markers of Induced Chemotherapy in Supraglottic Laryngeal Squamouscell Carcinoma","volume":"6","author":"Yang","year":"2020","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920911229","article-title":"Widespread Expression of Sonic Hedgehog (Shh) and Nrf2 in Patients Treated With Cisplatin Predicts Outcome in Resected Tumors and are Potential Therapeutic Targets for HPV-Negative Head and Neck Cancer","volume":"12","author":"Noman","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf9011","article-title":"Stem Cell Divisions, Somatic Mutations, Cancer Etiology, and Cancer Prevention","author":"Tomasetti","year":"2017","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tcb.2014.08.008","article-title":"Refining the Role for Adult Stem Cells as Cancer Cells of Origin","volume":"25","author":"White","year":"2015","journal-title":"Trends Cell Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.08.020","article-title":"Loss of TGFbeta Signaling Destabilizes Homeostasis and Promotes Squamous Cell Carcinomas in Stratified Epithelia","volume":"12","author":"Guasch","year":"2007","journal-title":"Cancer Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.01.045","article-title":"Foxf2 in Intestinal Fibroblasts Reduces Numbers of Lgr5(+) Stem Cells and Adenoma Formation by Inhibiting Wnt Signaling","volume":"144","author":"Nik","year":"2013","journal-title":"Gastroenterology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40364-019-0174-y","article-title":"Epigenetic Heterogeneity in Cancer","volume":"7","author":"Guo","year":"2019","journal-title":"biomark Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11246","article-title":"Highly Variable Cancer Subpopulations That Exhibit Enhanced Transcriptome Variability and Metastatic Fitness","author":"Nguyen","year":"2016","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor Angiogenesis: Causes, Consequences, Challenges and Opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.cell.2021.03.009","article-title":"Characterizing Genetic Intra-Tumor Heterogeneity Across 2,658 Human Cancer Genomes","author":"Dentro","year":"2021","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nature13556","article-title":"Non-Cell-Autonomous Driving of Tumour Growth Supports Sub-Clonal Heterogeneity","volume":"514","author":"Marusyk","year":"2014","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2649","article-title":"Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies","volume":"78","author":"Gallaher","year":"2018","journal-title":"Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026583","article-title":"Spatial Heterogeneity in the Tumor Microenvironment","volume":"6","author":"Yuan","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101574","article-title":"The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind","volume":"11","author":"Loponte","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S166514","article-title":"Transcobalamin I: A Novel Prognostic Biomarker of Neoadjuvant Chemotherapy in Locally Advanced Hypopharyngeal Squamous Cell Cancers","volume":"11","author":"Wang","year":"2018","journal-title":"Onco Targets Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8138","article-title":"P16 as a Prognostic Factor for the Response to Induction Chemotherapy in Advanced Hypopharyngeal Squamous Cell Carcinoma","volume":"15","author":"Lee","year":"2018","journal-title":"Oncol Lett"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqw145","article-title":"Clinical and Histologic Predictive Factors of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma","volume":"146","author":"Karpathiou","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25546","article-title":"Local Immune Parameters as Potential Predictive Markers in Head and Neck Squamous Cell Carcinoma Patients Receiving Induction Chemotherapy and Cetuximab","volume":"41","author":"Lad\u00e1nyi","year":"2019","journal-title":"Head Neck"},{"key":"B33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3892\/mco.2016.880","article-title":"PITX1 is a Novel Predictor of the Response to Chemotherapy in Head and Neck Squamous Cell Carcinoma","volume":"5","author":"Takenobu","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109306","article-title":"High Notch1 Expression Affects Chemosensitivity of Head and Neck Squamous Cell Carcinoma to Paclitaxel and Cisplatin Treatment","author":"Zhang","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S1808","DOI":"10.1016\/j.bjorl.2021.02.009","article-title":"Lysyl Oxidase Like-4 (LOXL4) as a Tumor Marker and Prognosticator in Advanced Stage Laryngeal Cancer","author":"Altunta\u015f","year":"2021","journal-title":"Braz J Otorhinolaryngol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810101)47:1","article-title":"Reporting Results of Cancer Treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-8049(99)00229-4","article-title":"Measurement of Clinical and Subclinical Tumour Response Using [18F]-Fluorodeoxyglucose and Positron Emission Tomography: Review and 1999 EORTC Recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group","volume":"35","author":"Young","year":"1999","journal-title":"Eur J Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.3.205","article-title":"New Guidelines to Evaluate the Response to Treatment in Solid Tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"B39","article-title":"Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials","volume":"47","author":"Shankar","year":"2006","journal-title":"J Nucl Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.anorl.2014.01.009","article-title":"[18f]-FDG PET-CT Prediction of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: Preliminary Findings","volume":"132","author":"Gavid","year":"2015","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/medicina54020031","article-title":"The Role of 18-Fluoro-2-Deoxy-Glucose Positron Emission Tomography\/Computed Tomography as Response and Prognosis Predictive Factor of Concurrent Chemoradiotherapy After Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Study","volume":"54","author":"\u0160edien\u0117","year":"2018","journal-title":"Medicina (Kaunas)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29188","article-title":"Single-Cycle Induction Chemotherapy Followed by Chemoradiotherapy or Surgery in Patients With Head and Neck Cancer: What are the Best Predictors of Remission and Prognosis","volume":"121","author":"Semrau","year":"2015","journal-title":"Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.11.013","article-title":"Induction Chemotherapy Followed by Radiotherapy for Larynx Preservation in Advanced Laryngeal and Hypopharyngeal Cancer: Outcome Prediction After One Cycle Induction Chemotherapy by a Score Based on Clinical Evaluation, Computed Tomography-Based Volumetry and 18F-FDG-PET\/Ct","volume":"72","author":"Wichmann","year":"2017","journal-title":"Eur J Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2015.01.013","article-title":"Tumor Plasma Flow Determined by Dynamic Contrast-Enhanced MRI Predicts Response to Induction Chemotherapy in Head and Neck Cancer","volume":"51","author":"Bernstein","year":"2015","journal-title":"Oral Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2463\/mrms.2015-0003","article-title":"Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-Weighted MRI at B-Values of 1,000 and 2,000 s\/Mm(2) to Predict Response to Induction Chemotherapy","volume":"14","author":"Ryoo","year":"2015","journal-title":"Magn Reson Med Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11040588","article-title":"Radiomic Model Predicts Lymph Node Response to Induction Chemotherapy in Locally Advanced Head and Neck Cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3318-8","article-title":"Score of Liver Ultrasonography Predicts Treatment-Related Severe Neutropenia and Neutropenic Fever in Induction Chemotherapy With Docetaxel for Locally Advanced Head and Neck Cancer Patients With Normal Serum Transamines","volume":"24","author":"Wang","year":"2016","journal-title":"Support Care Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24883","article-title":"Response Assessment After Induction Chemotherapy for Head and Neck Squamous Cell Carcinoma: From Physical Examination to Modern Imaging Techniques and Beyond","volume":"39","author":"de Bree","year":"2017","journal-title":"Head Neck"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3190","article-title":"Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study","volume":"25","author":"Liu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13244-020-00887-2","article-title":"Radiomics in Medical Imaging-\"How-to\" Guide and Critical Reflection","volume":"11","author":"van Timmeren","year":"2020","journal-title":"Insights Imaging"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092079","article-title":"Immune Cell Infiltrates and Neutrophil-To-Lymphocyte Ratio in Relation to Response to Chemotherapy and Prognosis in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas","volume":"13","author":"S\u00e1nchez-Canteli","year":"2021","journal-title":"Cancers"},{"key":"B53","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000499474","article-title":"Peripheral Inflammation Markers of Chemosensitivity to Induction Chemotherapy in Hypopharyngeal Cancer Patients","volume":"81","author":"Sun","year":"2019","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25699","article-title":"Dynamic Changes in Chemosensitivity Immune Predictors in Patients With Hypopharyngeal Cancer Treated With Induction Chemotherapy","volume":"41","author":"Sun","year":"2019","journal-title":"Head Neck"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132901","article-title":"Prognostic Role of Circulating Tumor Cells During Induction Chemotherapy Followed by Curative Surgery Combined With Postoperative Radiotherapy in Patients With Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer","volume":"10","author":"Inhestern","year":"2015","journal-title":"PloS One"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2019.11.037","article-title":"Normal BMI Predicts the Survival Benefits of Inductive Docetaxel, Cisplatin, and 5-Fluorouracil in Patients With Locally Advanced Oral Squamous Cell Carcinoma","volume":"39","author":"Zhao","year":"2020","journal-title":"Clin Nutr"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-016-0844-2","article-title":"Betel Nut Chewing History is an Independent Prognosticator for Smoking Patients With Locally Advanced Stage IV Head and Neck Squamous Cell Carcinoma Receiving Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil","volume":"14","author":"Su","year":"2016","journal-title":"World J Surg Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00007","article-title":"The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality","volume":"10","author":"Ferrari","year":"2020","journal-title":"Front Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010015","article-title":"Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Question of Belief","volume":"11","author":"Karabajakian","year":"2018","journal-title":"Cancers"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.7150\/jca.65315","article-title":"Optimize the Number of Cycles of Induction Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis","volume":"13","author":"Jiang","year":"2022","journal-title":"J Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8934","article-title":"(Docetaxel, Cisplatin, Fluorouracil) for Patients Unfit to Standard TPF in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study of 48 Patients","volume":"7","author":"Fayette","year":"2016","journal-title":"Oncotarget"},{"key":"B62","unstructured":""},{"key":"B63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.oraloncology.2019.09.013","article-title":"The Role of Single-Nucleotide Polymorphism (SNPs) in Toxicity of Induction Chemotherapy Based on Cisplatin and Paclitaxel in Patients With Advanced Head and Neck Cancer","volume":"98","author":"De Marchi","year":"2019","journal-title":"Oral Oncol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2018.08.003","article-title":"Toxicit\u00e9 De La Chimioth\u00e9rapie D\u2019induction Par Doc\u00e9taxel, Platine, 5-Fluorouracile (TPF) Pour Les Cancers Des Voies A\u00e9rodigestives Sup\u00e9rieures Localement \u00c9volu\u00e9s En Routine Clinique : Importance Du Statut Nutritionnel [Toxicity of Docetaxel, Platine, 5-Fluorouracil-Based Induction Chemotherapy for Locally Advanced Head and Neck Cancer: The Importance of Nutritional Status]","volume":"23","author":"Bernadach","year":"2019","journal-title":"Cancer Radiother"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24863","article-title":"Pretreatment Monocyte Counts and Neutrophil Counts Predict the Risk for Febrile Neutropenia in Patients Undergoing TPF Chemotherapy for Head and Neck Squamous Cell Carcinoma","volume":"9","author":"Shimanuki","year":"2018","journal-title":"Oncotarget"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13601","article-title":"Predictive Factors for Completion of TPF Induction Chemotherapy in Patients With Locally Advanced Head and Neck Cancer","volume":"39","author":"Nakano","year":"2019","journal-title":"Anticancer Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13440","article-title":"Usefulness of Hematological Inflammatory Markers in Predicting Severe Side-Effects From Induction Chemotherapy in Head and Neck Cancer Patients","volume":"39","author":"Mikoshiba","year":"2019","journal-title":"Anticancer Res"},{"key":"B68","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-59745-169-7_9","article-title":"New Tumor Biomarkers","volume-title":"Cancer Proteomics. Cancer Drug Discovery and Development","author":"Br\u00fcnner","year":"2008"},{"key":"B69","article-title":"Institute of Medicine","volume-title":"Initial National Priorities for Comparative Effectiveness Research","author":"Sox","year":""},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00827","article-title":"Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting","author":"Economopoulou","year":"2019","journal-title":"Front Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.6858","article-title":"Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting","volume":"30","author":"McShane","year":"2012","journal-title":"J Clin Oncol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-6-541","article-title":"Uses and Abuses of Tumor Markers in the Diagnosis, Monitoring, and Treatment of Primary and Metastatic Breast Cancer","volume":"11","author":"Henry","year":"2006","journal-title":"Oncologist"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S57023","article-title":"Recent Advances in the ARID Family: Focusing on Roles in Human Cancer","volume":"7","author":"Lin","year":"2014","journal-title":"Onco Targets Ther"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13355","article-title":"STC2 Promotes Head and Neck Squamous Cell Carcinoma Metastasis Through Modulating the PI3K\/AKT\/Snail Signaling","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8042489","article-title":"STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition","volume":"2019","author":"Lin","year":"2019","journal-title":"BioMed Res Int"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.7150\/thno.15625","article-title":"Role of the CXCL8-CXCR1\/2 Axis in Cancer and Inflammatory Diseases","volume":"7","author":"Ha","year":"2017","journal-title":"Theranostics"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.637226","article-title":"Asparagine Synthetase-Mediated L-Asparagine Metabolism Disorder Promotes the Perineural Invasion of Oral Squamous Cell Carcinoma","volume":"11","author":"Fu","year":"2021","journal-title":"Front Oncol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-GMB-2018-0005","article-title":"Mutational Landscape of Head and Neck Squamous Cell Carcinomas in a South Asian Population","volume":"4242","author":"Ghias","year":"2019","journal-title":"Genet Mol Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.900903\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:03:55Z","timestamp":1657127035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.900903\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":78,"alternative-id":["10.3389\/fonc.2022.900903"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.900903","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"article-number":"900903"}}